Freedom Investment Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-12,676
Closed -$388K 883
2021
Q2
$388K Buy
12,676
+116
+0.9% +$3.55K 0.03% 619
2021
Q1
$382K Sell
12,560
-2,294
-15% -$69.8K 0.03% 608
2020
Q4
$294K Buy
14,854
+2,668
+22% +$52.8K 0.03% 478
2020
Q3
$159K Buy
12,186
+150
+1% +$1.96K 0.02% 514
2020
Q2
$136K Sell
12,036
-2,248
-16% -$25.4K 0.01% 530
2020
Q1
$300K Sell
14,284
-304
-2% -$6.39K 0.03% 497
2019
Q4
$397K Sell
14,588
-3,308
-18% -$90K 0.04% 400
2019
Q3
$512K Buy
17,896
+1,948
+12% +$55.7K 0.04% 351
2019
Q2
$443K Sell
15,948
-13,660
-46% -$379K 0.04% 392
2019
Q1
$983K Buy
29,608
+4,156
+16% +$138K 0.08% 240
2018
Q4
$740K Sell
25,452
-10,217
-29% -$297K 0.06% 327
2018
Q3
$1.8M Sell
35,669
-1,734
-5% -$87.3K 0.11% 176
2018
Q2
$1.4M Buy
37,403
+10,313
+38% +$385K 0.08% 254
2018
Q1
$801K Buy
27,090
+1,083
+4% +$32K 0.04% 436
2017
Q4
$893K Sell
26,007
-214
-0.8% -$7.35K 0.05% 403
2017
Q3
$949K Sell
26,221
-11,084
-30% -$401K 0.05% 356
2017
Q2
$964K Buy
37,305
+2,196
+6% +$56.7K 0.05% 324
2017
Q1
$674K Buy
35,109
+18,904
+117% +$363K 0.04% 432
2016
Q4
$270K Buy
16,205
+743
+5% +$12.4K 0.02% 737
2016
Q3
$318K Sell
15,462
-2
-0% -$41 0.02% 611
2016
Q2
$473K Buy
15,464
+398
+3% +$12.2K 0.03% 429
2016
Q1
$564K Sell
15,066
-3,257
-18% -$122K 0.04% 361
2015
Q4
$791K Sell
18,323
-9,898
-35% -$427K 0.06% 263
2015
Q3
$338K Buy
28,221
+14,229
+102% +$170K 0.03% 436
2015
Q2
$476K Buy
13,992
+246
+2% +$8.37K 0.05% 354
2015
Q1
$487K Buy
13,746
+2,533
+23% +$89.7K 0.05% 314
2014
Q4
$382K Buy
11,213
+949
+9% +$32.3K 0.05% 346
2014
Q3
$396K Buy
10,264
+308
+3% +$11.9K 0.07% 275
2014
Q2
$387K Buy
9,956
+209
+2% +$8.12K 0.07% 282
2014
Q1
$333K Buy
+9,747
New +$333K 0.07% 270
2013
Q3
Sell
-18,149
Closed -$488K 399
2013
Q2
$488K Buy
+18,149
New +$488K 0.17% 106